Search results for "IBA"

showing 10 items of 1355 documents

Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. Diputadas, ministras y cargos institucionales

2014

“Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. Diputadas, ministras y cargos institucionales” es la primera parte de un trabajo de documentación para un capítulo de “La democracia en la Comunidad Valenciana. Partidos, elites políticas, elecciones y programas políticos”. “Mujer, poder político y democracia paritaria”. Se recoge el papel de la mujer en la vida política de la Comunidad Valenciana en la democracia actual, desde 1977. Es documentación sin elaborar, pero que aporta datos de la presencia de la mujer en las instituciones, partidos y sindicatos. Cuando este completa será una parte de la investigación referida, y de la que ya hay dos publicacion…

:CIENCIA POLÍTICA [UNESCO]UNESCO::HISTORIAUNESCO::CIENCIA POLÍTICA:HISTORIA [UNESCO]Dolores Ibarruri Pasionaria. Josefina López Sanmartín PCE. Ciprià Císcar Casabán. Pilar Brabo Castells. Palmira Pla Pechoviento. Adela Pla Pastor. democracia paritaria. Asunción Cruañes Molina. Carmen Alborch Bataller. Maria A. Armengol Criado. Clementina Rodenas Villena. Rita Barberá Nolla. Irma Simón Calvo. Teresa Sempere Jaén. Ofelia Soler Nomdedeu. María C. Díaz Villanueva. María Carmen Pardo Raga. Eva María Amador Guillén. Presentación Urán González. María Isabel Díez de la Lastra Barbadillo. Elena Irene Martín Crevillén. María Enriqueta Seller Roca de Togores. María Carmen Pardo Raga. Eva María Amador Guillén. María J. Mora Devis. Olga Mulet Torres. Margarita Pin Arboledas. Juana Serna Masiá. Leire Pajín Iraola. Rosa M. Peris Cervera. Amparo Ferrando. Carmen Arjona. María I. España Moya. Federica Montseny Mañé. Matilde Fernández Sanz. Rosa Conde Gutiérrez del Álamo. María de los Ángeles Amador Millán. Cristina Alberdi Alonso. Margarita Mariscal de Gante Mirón. Esperanza Aguirre Gil de Biedma. Loyola de Palacio del Valle-Lersundi. Isabel Tocino Biscarolasaga. Pilar del Castillo Vera. Celia Villalobos Talero. Anna María Birulés Beltrán Ana Pastor. Ana de Palacio del Valle-Lersundi. Elvira Rodríguez Herrero. Julia García-Valdecasas. Ana Mª Castellanos Vilar. Elena Mª Martín Yánez. Paloma Gómez Osorio. Concepción Pérez Morales. Francisca Benabent Fuentes. Carmen Monzó Juan. Rosa Mª Morte Julián. Gloria Marcos Martí. Lourdes Alonso Belza. Pilar Pedraza. María García-Lliberos Sánchez-Robles. Blanca Blanquer. Dolors Giner Duran. Teresa Fluvía Rodríguez. Trinidad Simó. Emilia Noguera. Hortensia Moriones Almaraz. Carolina García Mahiques. Hortensia Moriones Almaraz. Juana Serna Maciá. Lourdes Alonso Belza. Inmaculada Rodríguez-Piñero Fdez. Carmen Macián Armengod. Carmen Moya García. María José López Rodenas. María Juan Millet. Alicia de Miguel García. Ana Encabo Balbín. Ana Michavila Nuñez. Isabel Villalonga Campos. Carmen Dolz Adell. Eva Maria Amador Guillen. Alida C. Mas Taberner. Dora Ibars Sancho. Amparo Koninckx Frasquet. Blanca Martínez de Vallejo Fuster. Consuelo Císcar Casabán. Auxiliadora Hernández Miñana. Silvia Caballer Almela. Gemma Amor Pérez. Emma Iranzo Martín. Cristina Serrano Mateo. Cristina Santamarina Ciurana
researchProduct

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

2007

Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…

:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Veterinary medicine:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Streptomycin [Medical Subject Headings]:Phenomena and Processes::Microbiological Phenomena::Drug Resistance Microbial [Medical Subject Headings]DiseaseGlobal Health:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Health Care::Population Characteristics::Health::World Health [Medical Subject Headings]Terminología como AsuntoBrucellosi:Organisms::Eukaryota::Animals [Medical Subject Headings]:Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings]Policy ForumMedicine in Developing CountriesGentamicinasDrug Resistance MicrobialBrucelosisAdhesión a DirectrizGeneral MedicineHumanosDrug CombinationsAntibacterianosDoxycyclineStreptomycinEstreptomicinaMedicine:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds with 4 or More Rings::Rifamycins::Rifampin [Medical Subject Headings]Drug Therapy CombinationGuideline AdherenceRifampinFluoroquinolonesSalud Mundialmedicine.medical_specialtyEfficacyResultado del TratamientoInvestigación BiomédicaRecurrenciaTherapeuticsWorld Health OrganizationMicrobiologyAntibiotic resistanceTerminology as Topic:Disciplines and Occupations::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]HumansMedical journalIntensive care medicineDeveloping Countries:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Trimethoprim::Trimethoprim-Sulfamethoxazole Combination [Medical Subject Headings]medicine.diseaseCotrimoxazoleAnimalesQuimioterapia:Humanities::Humanities::History::History Modern 1601-::History 21st Century [Medical Subject Headings]GentamicinsBrucel·losiBiomedical ResearchCommunicable diseases:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 2-Ring::Quinolines::Quinolones::Fluoroquinolones [Medical Subject Headings]Human diseaseRecurrence:Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings]:Information Science::Information Science::Communication::Language::Linguistics::Terminology as Topic [Medical Subject Headings]biologyIraqi patientsRMetaanalysis:Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Brucellosis [Medical Subject Headings]Historia del Siglo XXIAnti-Bacterial AgentsCombinación Trimetoprim-SulfametoxazolTreatment OutcomeInfectious Diseases:Disciplines and Occupations::Natural Science Disciplines::Science::Research::Biomedical Research [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Tetracyclines::Doxycycline [Medical Subject Headings]Fluoroquinolonas:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicins [Medical Subject Headings]Países en Desarrollo:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy Combination [Medical Subject Headings]BrucellaHistory 21st CenturyBrucellosisWorld healthTrimethoprim Sulfamethoxazole Drug CombinationmedicineAnimals:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Resistencia a Medicamentosbusiness.industryOrganización Mundial de la SaludBrucellosisMalalties infecciosesTerapèuticabiology.organism_classificationCombinación de MedicamentosDoxiciclinaTherapybusinessBrucella melitensisPLoS Medicine
researchProduct

Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey

2022

Infection control; Multidrug resistance; Stewardship Control de infección; Resistencia a múltiples fármacos; Administración Control d'infecció; Resistència a múltiples fàrmacs; Administració We explored the self-reported antibiotic stewardship (AS), and infection prevention and control (IPC) activities in intensive care units (ICUs) of different income settings. A cross-sectional study was conducted using an online questionnaire to collect data about IPC and AS measures in participating ICUs. The study participants were Infectious Diseases–International Research Initiative (IDI-IR) members, committed as per their institutional agreement form. We analyzed responses from 57 ICUs in 24 countri…

:Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]EpidemiologyIntensive Care UnitInfection controlAmerica:acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos [COMPUESTOS QUÍMICOS Y DROGAS]Multidrug resistanceCommunicable DiseasesEnquestesPan drug resistanceCommunicable DiseaseAntimicrobial StewardshipSurveys and QuestionnairesAnti-Bacterial AgentHumansMedicaments antibacterians - Ús terapèuticStewardshipSurveys and QuestionnaireSocietyUnitats de cures intensivesCross-Sectional StudieInfection ControlCross InfectionPreventionPublic Health Environmental and Occupational Health:técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]General MedicineMDROAnti-Bacterial AgentsIntensive Care Units:Health Care Facilities Manpower and Services::Health Facilities::Hospital Units::Intensive Care Units [HEALTH CARE]Cross-Sectional StudiesInfectious Diseases:instalaciones servicios y personal de asistencia sanitaria::centros sanitarios::unidades hospitalarias::unidades de cuidados intensivos [ATENCIÓN DE SALUD]:Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [CHEMICALS AND DRUGS]Self ReportMDROsLow- and upper-middle and high incomeHuman
researchProduct

Construcción y validación de un sistema de detección precoz de trastornos de desarrollo (SDPTD) en niños de 18, 24, y 36 meses

2013

En esta tesis se pretende contruir una herramienta de detección precoz que detecte cualquier alteración que se produzca en el desarrollo del niño como una medida preventiva de posibles trastornos posteriores más graves. En esta investigación se ha diseñado una herramienta basada en web y apoyada en videos para facilitar a las familias la administración. El sistema esta compuesto de 7 cuestionarios pero en esta tesis estan validados los 3 cuestionarios (18 meses, 24 meses y 36 meses). Los cuestionarios se pueden encontrar en: https://cudap.uv.es/ProyectoC/

:PSICOLOGÍA::Psicología del niño y del adolescente [UNESCO]:PSICOLOGÍA::Evaluación y diagnóstico en psicología [UNESCO]screening:PSICOLOGÍA [UNESCO]retraso psicomotordesarrollo evolutivodetección precozUNESCO::PSICOLOGÍAcribado del desarrollointervención tempranasistemas de detecciónUNESCO::PSICOLOGÍA::Psicología del niño y del adolescenteUNESCO::PSICOLOGÍA::Evaluación y diagnóstico en psicologíatrastornos del desarrollo
researchProduct

Análisis coste-utilidad de la triple terapia con telaprevir en pacientes con hepatitis C no tratados previamente

2014

Introducción: En España, con una prevalencia del 2,5%, la hepatitis C (VHC) se asocia a una elevada morbi-mortalidad. El tratamiento combinado de telaprevir y peginterferon/ribavirina ([T/PR]) es eficaz en pacientes con VHC-G1. El objetivo primario de este estudio fue evaluar la relación coste-utilidad (RCUI) de [T/PR] versus peginterferon alfa 2a/ribavirina ([PR]) en pacientes naïve VHC-G1, según el grado de fibrosis y bajo la perspectiva del sistema sanitario español. Metodología: La eficacia y la incidencia de efectos adversos (EAs) se obtuvieron de los estudios ADVANCE y OPTIMIZE. La estimación de los costes de monitorización, de manejo de EAs y de la enfermedad por estados de salud (€,…

; Genotype 1lcsh:RRibavirinalcsh:Medicinelcsh:RS1-441Genotype 1Hepatitis CTelaprevirGenotipo 1lcsh:Pharmacy and materia medicaCoste-utilidadCost-effectivenessPeginterferon alfa 2aRibavirinehealth care economics and organizationsFarmacia Hospitalaria
researchProduct

Chemical Composition and antimicrobial activity of the essential oils from two species of Thimus growing wild in southern Italy

2009

The volatile constituents of the aerial parts of two samples of Thymus longicaulis C. Presl, collected in Campania and in Sicily, and two samples of Thymus pulegioides L. from the same regions, were extracted by hydrodistillation and analyzed. Considering the four oils together, seventy-eight different compounds were identified: 57 for Thymus longicaulis from Sicily (91.1% of the total oil), 40 for Thymus longicaulis from Campania (91.5% of the oil), 39 for Thymus pulegioides from Sicily (92.5% of the oil) and 29 for Thymus pulegioides from Campania (90.1% of the oil). The composition of the oils is different, although the most abundant components are identical in T. pulegioides. The essent…

<em>Thymus longicaulis</em> C. Presl; <em>Thymus pulegioides </em>L.; essential oil composition; thymol; geraniol; antibacterial activityThymus pulegioidesPharmaceutical ScienceMicrobial Sensitivity TestsArticleAnalytical Chemistrylcsh:QD241-441Thymus Plantchemistry.chemical_compoundlcsh:Organic chemistryantibacterial activitythymolDrug DiscoveryBotanyOils VolatilePlant OilsThymus PlantSettore BIO/15 - Biologia FarmaceuticaPhysical and Theoretical ChemistrygeraniolThymolChemical compositionessential oil compositionThymus longicaulisbiologyBacteriaThymus pulegioides L.Organic ChemistrySettore CHIM/06 - Chimica Organicabiology.organism_classificationAntimicrobialAnti-Bacterial AgentschemistryItalyantimicrobial activity essential oils Thimus longicaulis Thimus pulegioidesChemistry (miscellaneous)Molecular MedicineComposition (visual arts)Thymus longicaulis C. PreslGeraniol
researchProduct

Yield measurements at IGISOL with a digital data acquisition system

2017

A new digital data acquisition system has been installed at the IGISOL facility at the department of Physics in University of Jyväskylä in November, 2016. The technical details of the hardware and software of this new system are presented in this thesis. Nutaq VHS-ADC digital data acquisition system includes an analogue to digital converter (ADC) crate board, an offset unit box, an acquisition host PC, and a storage drive. This system consists of 8 channels, has the capability of 105 MSPS with 14-bit ADCs on 6U cPCI (PXI compatible). Radioactive sources, beta-gamma matrix, gamma-gamma matrix, beta-delayed gamma, and gamma-delayed gamma spectra of radioactive isotopes produced at IGISOL were…

ADCMCPJYFLTRAPA/DBEDACIGISOLIBACFDSPIGtiedonsiirtoTDCtietojärjestelmät
researchProduct

Antibiotiku atliekvielu noteikšana un izplatība zivīs

2022

Akvakultūra mūsdienu pasaulē tiek uzskatīta par strauji augošu industriju, kur gandrīz puse no tās veido zivs, kuru lieto cilvēki savā uzturā. Ražošanā tiek izmantoti lieli zivju krājumi, tomēr bieži notiek slimību uzliesmojumi, kā rezultātā tiek pielietoti antibakteriālie līdzekļi, kas ir kļuvuši par ierastu praksi. Antibiotikas ir medikamenti, kas nomāc baktēriju augšanu un izraisa to nāvi, tās tiek pielietotas gan cilvēku, gan arī veterinārmedicīnā pret bakteriālām infekcijām. Ir zināmi vairāk kā 100 savienojumi, un jauno savienojumu sintēze ir praktiski apstājusies. Šo savienojumu grupas atliekvielu izplatība rada rezistences pieaugšanu, ietekmējot apkārtējo vidi un sabiedrības veselība…

ANTIBAKTERIĀLĀ REZISTENCEMASSPEKTROMETRIJAANTIBIOTIKASHROMATOGRĀFIJAĶīmija
researchProduct

Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study.

2013

We previously described the isolation and characterization of three probiotic strains from the feces of exclusively breast-fed newborn infants: Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036. These strains were shown to adhere to intestinal mucus in vitro, to be sensitive to antibiotics and to resist biliary salts and low pH. In the present study, a multicenter, randomized, double-blind, placebo-controlled trial with 100 healthy volunteers in three Spanish cities was carried out to evaluate the tolerance, safety, gut colonization and immunomodulatory effects of these three probiotics. Volunteers underwent a 15-day washout perio…

ARN Bacterianoved/biology.organism_classification_rank.speciesPhysiologylcsh:Medicine:Phenomena and Processes::Biological Phenomena::Ecological and Environmental Phenomena::Environment::Ecosystem::Biodiversity::Biota::Microbiota [Medical Subject Headings]law.inventionFecesProbioticAntibioticslawLactobacillus:Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Child Nutritional Physiological Phenomena::Infant Nutritional Physiological Phenomena::Breast Feeding [Medical Subject Headings]lcsh:Science:Chemicals and Drugs::Nucleic Acids Nucleotides and Nucleosides::Nucleic Acids::RNA::RNA Bacterial [Medical Subject Headings]BifidobacteriumMultidisciplinaryBifidobacterium brevebiologyLacticaseibacillus rhamnosusMicrobiotaHibridación in SituInterleukin-10:Organisms::Bacteria::Gram-Positive Bacteria::Lactobacillales::Lactobacillaceae::Lactobacillus [Medical Subject Headings]Breast FeedingBloodCytokinesFemaleResearch ArticleAdult:Anatomy::Fluids and Secretions::Feces [Medical Subject Headings]Lactobacillus paracasei:Organisms::Bacteria::Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Rods::Clostridium::Clostridium difficile [Medical Subject Headings]Microbiology:Chemicals and Drugs::Nucleic Acids Nucleotides and Nucleosides::Nucleic Acids::Nucleic Acid Probes::Oligonucleotide Probes [Medical Subject Headings]Double-Blind MethodLactobacillus rhamnosusHumansImmunologic Factors:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Histocytological Preparation Techniques::Staining and Labeling::In Situ Hybridization [Medical Subject Headings]FecesSafety studiesved/biologyProbioticslcsh:RClostridium difficile:Organisms::Bacteria::Gram-Positive Bacteria::Actinobacteria::Bifidobacterium [Medical Subject Headings]biology.organism_classificationImmunoglobulin ALactobacilluslcsh:QInterleukin-4BifidobacteriumBreast feedingSondas de OligonucleótidosPLoS ONE
researchProduct

Metabolic shift of polyphosphate-accumulating organisms with different levels of polyphosphate storage

2012

Previous studies have shown that polyphosphate-accumulating organisms (PAOs) are able to behave as glycogen-accumulating organisms (GAOs) under different conditions. In this study we investigated the behavior of a culture enriched with Accumulibacter at different levels of polyphosphate (poly-P) storage. The results of stoichiometric ratios Gly degraded/HAc uptake, PHB synthesized/HAc uptake, PHV synthesized/HAc uptake and P release/HAc uptake confirmed a metabolic shift from PAO metabolism to GAO metabolism: PAOs with high poly-P content used the poly-P to obtain adenosine tri-phosphate (ATP), and glycogen (Gly) to obtain nicotinamide adenine dinucleotide (NADH) and some ATP. In a test whe…

Accumulibacter Type IIWaste component removalUnclassified drugPhysiologyChemical compositionMicrobial metabolismStorageWastewaterNicotinamide adenine dinucleotidePolyhydroxyalkanoic acidchemistry.chemical_compoundBacteriumBioreactorsPolyphosphatesGlycolysisAnaerobiosisBiomassPolyphosphate-accumulating organismsWaste Management and DisposalAccumulibacter Type IGlycogen accumulating organismPriority journalWater Science and TechnologyFluorescence microscopyPolyhydroxyvalerateSewageGlycogenHydrolysisFluorescence in situ hybridizationEcological ModelingPhosphorusHydrogen-Ion ConcentrationBioaccumulationPollutionStoichiometryWaste treatmentPolyphosphate-accumulating organismsBiodegradation EnvironmentalEnhanced biological phosphorus removalBiochemistryGlycogen-accumulating metabolism (GAM)Nicotinamide adenine dinucleotideAccumulibacter type 1Accumulibacter type 2GlycolysisGlycogenMetabolic Networks and PathwaysAccumulibacterAdenosine triphosphateEnvironmental EngineeringBiologyAcetic acidArticleAssociative storagePolyphosphate-accumulating metabolism (PAM)PolyphosphateGlycogen-accumulating organismsGlycogen-accumulating metabolismsTECNOLOGIA DEL MEDIO AMBIENTEPolyphosphate accumulating organismCivil and Structural EngineeringPolyphosphate-accumulating organisms (PAO)BacteriaPolyphosphateMetabolismIn situ measurementGlycogen-accumulating organisms (GAO)Polyphosphate-accumulating metabolismsNonhumanAmidesCarbonMetabolismchemistryPolyphosphate (poly-P)Bacterial metabolismCell cultureVolatilizationWater Research
researchProduct